Stay updated with breaking news from Microcap Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FingerMotion, Inc. (NASDAQ: FNGR) is steadily gaining attention from online investors as the company takes a stand against potential fraudulent short activity. We've previously covered FNGR, most notably in articles from July and September. However, the latest developments are too significant to ignore, prompting us to revisit the subject. Just recently, FNGR issued a press
Galera Therapeutics (NASDAQ: GRTX) experienced a significant 34% intraday surge on October 18, 2023. This explosive trading has captured the attention of investors, prompting curiosity about the company's efforts to innovate radiotherapy in cancer treatment. Despite the lack of updates on social media, press releases, or SEC filings, this sudden rise has left many intrigued
SAB Biotherapeutics (NASDAQ: SABS), gained 28% today as the clinical-stage biopharmaceutical company pioneering a novel immunotherapy platform received approval from the Australian Human Research Ethics Committee (HREC) to initiate the first-in-human Phase 1 clinical trial of SAB-142. Type 1 Diabetes Asset: SAB-142 is a fully-human anti-thymocyte immunoglobulin designed to modify the progression of type 1
Astra Energy Inc. (OTCQB: ASRE) has witnessed a significant shift in its market valuation since this summer of 2023, boasting an impressive growth of approximately 280% from the lows in July to the peaks in September. Additionally, the company has gained substantial traction among online investors, attributed to its ongoing initiatives to advance renewable and
Nkarta, Inc. (Nasdaq: NKTX) is making headlines with a staggering 120% surge in its share value at the present time of writing. This remarkable growth is attributed to the biopharmaceutical company's groundbreaking work in engineered natural killer (NK) cell therapies and its recent approval from the U.S. Food and Drug Administration (FDA). For a clearer